SPECIAL NOTICE

We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.

SEARCH BY NAME

BROWSE

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH BY CODE

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

JUSTKAPITAL LIMITED (JKL)

Former Name ASX

SHARE PRICES

Former (or subsequent) names

 FROMTO
LAWFINANCE LIMITED31/12/2018
JUSTKAPITAL LIMITED03/02/201731/12/2018
JUSTKAPITAL LITIGATION PARTNERS LIMITED27/02/201503/02/2017
AFRICAN CHROME FIELDS LIMITED28/02/201427/02/2015
TPL CORPORATION LIMITED15/05/200828/02/2014
TERRAPLANET LIMITED06/06/200115/05/2008
TERRAPLANET.COM LIMITED06/06/2001

Shareholder links

Our website ranking of JKL: rating 5
(5 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Link Market Services, Level 12 QV1 Building 250 St Georges Terrace Perth WA 6000

Tel : +61 8 9211 6670 or 1300 554 474
Fax : +61 2 9287 0303
RegistryWebsite RegistryEmail

Company details

Address: Suite 2, Level 16 56 Pitt Street Sydney NSW 2000
Tel:  +61 2 9696 0220 Fax: 

Date first listed: 12/05/2000
Company Secretary: Dean Jagger
Sector: Diversified Financials Industry Group: XFJ
Activities: Provision of news, information, consumer services and entertainment through various magazine brands and a network of websites

name changed to LawFinance Limited

31/12/2018

The securities of JustKapital Limited ("˜JKL') are expected to be reinstated to Official Quotation at the commencement of trading at 10:04:30am AEDT on Wednesday, 2 January 2019. It is expected that, for ASX purposes, the change of name from JustKapital Limited to LawFinance Limited, and the change of code from JKL to LAW, will be effective on Monday, 31 December 2018

28/12/2018

An additional l 1,264,569 fully paid ordinary shares are due to be released from escrow on 31 December 2018. The total number of restricted securities due to be released from escrow on 31 December 2018 are as follows: 2,695,729 fully paid ordinary shares with release date of 31 December 2018.

14/12/2018

The offer under the cleansing prospectus dated 13 December 2018 has closed, which will result in $8 (before costs) being raised via the issue 100 new shares at an issue price of $0.08 per share.

13/12/2018

The company issues a cleansing prospectus for the offer of 100 Shares at an issue price of $0.08 per New Share to investors, who are invited by the Company to subscribe for New Shares under this Prospectus.

13/12/2018

The following restricted securities are due to be released from escrow on the following date: 1,431,160 - fully paid ordinary shares - release date: 31 December 2018.

11/12/2018

The company releases its mended Constitution.

19/11/2018

The company releases the Results of Meeting.

15/11/2018

The company releases an AGM Presentation.

15/11/2018

The company releases a Corporate Governance Statement.

01/11/2018

The company provides commentary on the Appendix 4C for the quarter ended 30 September 2018. Trading update is as follows: The Australian Net Receivables (net of provisions for doubtful debts and discounts) grew 5.5% to $37.6M and is expected to be collected from our legal firm clients over the next 24 months. An update on National Health Finance - The US Net Receivables (net of provisions for doubtful debts and discounts), as at 30 June 2018, was US$94.9M (A$135.6M) and these are expected to be collected over the next 36-48 months.

31/10/2018

The company lodges an Appendix 4C - quarterly.

31/10/2018

ASX is in the process of reviewing the Company's application for recompliance with Chapters 1 and 2 of the ASX Listing Rules in accordance with ASX Listing Rule 11.1.3. Therefore, the Company's securities will remain suspended until the ASX has confirmed its Recompliance.

23/10/2018

The company's nonrenounceable pro rata rights issue of up to 147,933,598 new ordinary shares in the Company closed at 5pm on Wednesday, 17 October 2018. In line with this, the company releases a notification of under subscriptions.

22/10/2018

The company releases the Open Briefing interview with CEO on Acquisition of NHF.

15/10/2018

The company releases a notice of AGM. The AGM will be held at 10:30am on Thursday 15 November 2018 at Bennelong Room DEXUS Place Level 15, Governor Macquarie Tower 1 Farrer Place Sydney NSW 2000.

10/10/2018

The company releases its Investor Presentation.

09/10/2018

The Company is pleased to advise of its change of name to "˜LawFinance Limited' following approval at the extraordinary meeting of shareholders on 26 September 2018 and the change being recorded on the Australian Securities and Investments Commission's records effective 1 October 2018. The expected effective date for the change to the company's name and ticker code on the ASX platform is 26 October 2018.

03/10/2018

Following strong support from its shareholders at the recent Extraordinary General Meeting, it has successfully closed the acquisition of National Health Finance HoldCo, LLC for US$53m. All conditions precedent to the Transaction were satisfied or waived and the Transaction was completed in the US on 28 September 2018.

02/10/2018

The company provides an updated timetable in respect e non-renounceable pro rata rights issue set out in the prospectus.

28/09/2018

The company sends a letter to its shareholders regarding the non-renounceable pro rata rights issue of up to 147,933,598 Shares, under which each Eligible Shareholder may apply for one New Share for every one Existing Share held by the Eligible Shareholder on the Record Date (being 7.00pm (Sydney time) on 1 October 2018), at an issue price of $0.08 per Share to raise up to approximately A$11.8 million (before costs).

27/09/2018

The company releases the results of its EGM.

26/09/2018

The company has obtained shareholder approval for the acquisition of leading US personal injury financier National Health Finance HoldCo, and that the Company expects to close the transaction on 28 September 2018. The acquisition price of US$53m for the purchase of 100% of NHF will be funded by a combination of cash and JustKapital scrip. The cash component will be funded through a A$42m syndicated loan facility which is expected to settle tomorrow.

26/09/2018

The company issues a prospectus for the offer of one JustKapital New Share for every one JustKapital Existing Share at an issue price of A$0.08 per JustKapital New Share "“ up to 147.93 million new fully paid ordinary shares in JustKapital. The Prospectus Offer is scheduled to close at 5:00pm on 15 October 2018 unless extended or withdrawn. Applications must be received before that time to be valid.

21/09/2018

The company releases an Investor Presentation.

04/09/2018

The company releases an Appendix 4G.

03/09/2018

The company lodges its Appendix 4E and Annual Report.

31/08/2018

The company releases a sample proxy form which will be included with the notice of meeting to be dispatched to shareholders.

24/08/2018

The company despatches a notice of meeting to its shareholders. The EGM will be held at Bligh Room DEXUS Place Level 15, Governor Macquarie Tower 1 Farrer Place Sydney NSW 2000 at 10:00am (Sydney Time) on 26 September 2018.

24/08/2018

Following a scheduled ASX internal system change affecting the Market Announcements Platform, it has been necessary to re-apply the "˜Suspend' session state. This announcement serves to re-confirm the securities of this entity remain suspended.

06/08/2018

The company provides commentary on the Appendix 4C for the quarter ended 30 June 2018 and an update on its trading to 30 June 2018.

01/08/2018

The company lodges its Appendix 4C - June 2018.

01/08/2018

On 18 July 2018, the company entered into 2 conditional Securities Purchase Agreements to acquire a 100% interest in United States personal injury financier National Health Finance HoldCo, LLC for A$68.8m.

19/07/2018

The securities of JustKapital Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of the Company, pending the release of an announcement regarding a proposed acquisition.

19/07/2018

The suspension of trading in the securities of JustKapital Limited will be lifted immediately, following receipt of an announcement by the Company regarding the proposed acquisition of the National Health Finance Business and transfer of the Litigation Funding Portfolio to the Litigation Finance Trust.

04/12/2017

The proposed 70% acquisition of the US personal injury litigation financing business National Health Finance will no longer be pursued in its current structure. Despite the Company's best efforts, JustKapital has been unable to secure sufficient debt and equity funding in a timeframe deemed acceptable since the transaction became public knowledge. The Company will update the market should the transaction be revisited under an alternative structure. The company has reached favourable terms with Mr Philip Kapp resulting in Mr Kapp assuming management rights over the majority of the Group's funded cases which will be transferred into the Litigation Finance Trust.

04/12/2017

The company releases the results of its meeting.

29/11/2017

The company releases its AGM Opening Address.

29/11/2017

The securities of JustKapital Limited will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement regarding the proposed acquisition of the National Health Finance Business and transfer of the Litigation Funding Portfolio to the Litigation Finance Trust.

22/11/2017

The company provides a market update in connection with the acquisition of an interest in National Health Finance. JustKapital will seek shareholder approval of the NHF transaction at its 2017 annual general meeting. Completion of the transaction is subject to several conditions, including commitment of a debt facility, shareholder approval and completion of an equity capital raising.

20/09/2017

The suspension of trading in the securities of JustKapital Limited will be lifted immediately, following receipt of an announcement by the Company regarding its proposed acquisition of the National Health Finance business.

20/09/2017

The company announces governance and remuneration changes.

18/09/2017

The company has received confirmation from ASX that it will not be required to meet afresh the requirements in Chapters 1 and 2 of the Listing Rules in connection with the proposed acquisition of an interest in National Health Finance.

15/09/2017

The company has signed a conditional Securities Purchase Agreement to acquire 70% of National Health Finance.

12/09/2017

The company has not yet received ASX's determination on the application of Chapter 11 of the ASX Listing Rules to the company's proposed acquisition of the National Health Finance business.

11/09/2017

The securities of JustKapital Limited will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement regarding a determination by ASX in relation to the application of chapter 11 of the ASX Listing Rules to the Company's proposed acquisition of the National Health Finance business.

06/09/2017

name changed from JustKapital Litigation Partners Limited

03/02/2017

ASX Announcements (courtesy of ASX)

 

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...


    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    31/01/2018Timothy Storey634,955$0.079$50,346
    25/01/2018Diane Jones74,637$0.077$5,747
    16/01/2018Diane Jones633,363$0.086$54,298
    12/01/2018Anthony Murphy85,000$0.082$6,970
    03/10/2017Philip Kapp220,000$0.183$40,300

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Timothy StoreyNon Exec Chairman04/08/2014
    Anthony HerschCOO27/11/2017
    Jonny AllattCOO02/04/2015
    Craig BeattonCFO27/11/2017
    Anthony MurphyNon Exec Director31/10/2017
    Diane JonesDirector, CEO04/03/2016
    David WattelDirector26/09/2018

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Mike HillNon Exec Director30/03/201527/11/2017
    Philip KappChairman, Managing Director04/08/201431/10/2017
    Hugh WarnerExecutive Chairman17/05/201015/01/2016
    Harry GreavesNon Exec Director19/08/201311/02/2015
    Neil HackettNon Exec Director09/06/201108/08/2014
    James PrattDirector28/10/200928/02/2014
    Mark GuntherManaging Director07/06/201006/02/2012

    Date of first appointment, title may have changed.